BlackRock Capital Allocation Term Trust (NYSE:BCAT) Shares Up 0.7% – What’s Next?

Posted by Stanley Muller on Aug 4th, 2026

BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) shot up 0.7% during mid-day trading on Monday . The stock traded as high as $15.92 and last traded at $15.8650. Approximately 741,994 shares traded hands during mid-day trading, an increase of 2% from the average session volume of 724,242 shares. The stock had previously closed at $15.76.

BlackRock Capital Allocation Term Trust Trading Up 0.7%

The business’s 50-day moving average is $15.74 and its two-hundred day moving average is $15.19.

BlackRock Capital Allocation Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be given a $0.2542 dividend. This represents a c) dividend on an annualized basis and a yield of 19.2%. The ex-dividend date of this dividend is Tuesday, September 15th.

Hedge Funds Weigh In On BlackRock Capital Allocation Term Trust

Several hedge funds have recently modified their holdings of BCAT. Geneos Wealth Management Inc. lifted its position in shares of BlackRock Capital Allocation Term Trust by 341.7% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock worth $31,000 after buying an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC grew its holdings in shares of BlackRock Capital Allocation Term Trust by 100.0% in the fourth quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after acquiring an additional 1,200 shares in the last quarter. McIlrath & Eck LLC increased its position in shares of BlackRock Capital Allocation Term Trust by 169.6% during the first quarter. McIlrath & Eck LLC now owns 3,130 shares of the company’s stock valued at $44,000 after acquiring an additional 1,969 shares during the last quarter. Parallel Advisors LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust during the third quarter valued at approximately $47,000. Finally, Brown Brothers Harriman & Co. lifted its holdings in BlackRock Capital Allocation Term Trust by 450.0% during the third quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock worth $81,000 after acquiring an additional 4,500 shares during the period. Institutional investors own 36.12% of the company’s stock.

About BlackRock Capital Allocation Term Trust

(Get Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.